Illumina (ILMN) Earnings Analysis
Illumina (ILMN) next reports earnings on 2026-07-30, consensus EPS 1.23 USD. Last quarter (2026-04-30) it beat with EPS 1.15 USD vs 1.05 USD est (+9.5%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 34.45.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ILMN next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 1.23 USD |
| Revenue estimate | 1.13B |
ILMN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 1.15 USD | 1.05 USD | +9.5% | Beat |
| 2026-02-05 | 1.35 USD | 1.24 USD | +8.9% | Beat |
| 2025-10-30 | 1.34 USD | 1.17 USD | +14.5% | Beat |
| 2025-07-31 | 1.19 USD | 1.02 USD | +16.7% | Beat |
| 2025-02-06 | 0.86 USD | 0.92 USD | -6.5% | Miss |
| 2024-11-04 | 1.14 USD | 0.879 USD | +29.7% | Beat |
Beat rate: 5/6 (83%) over reported quarters with consensus data.
ILMN valuation and analyst view
| Trailing P/E | 34.45 |
|---|---|
| Trailing EPS | 5.575 USD |
| Price / book | 10.91 |
| Dividend yield | 0.00% |
| Market cap | 29.24B |
| Analyst consensus | Buy (26 buy / 18 hold / 6 sell) |
| Avg price target | 172.44 USD |
Related research pages
Frequently asked questions
When is Illumina (ILMN)'s next earnings date?
Illumina is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 1.23 USD and revenue estimate of 1.13B.
Did ILMN beat earnings last quarter?
In its 2026-04-30 report, ILMN posted EPS of 1.15 USD versus a 1.05 USD estimate — a beat of 9.5%.
What is ILMN's earnings track record?
Over the last 6 reported quarters with consensus data, ILMN beat estimates 5 times (83%).
What is ILMN's current P/E ratio and EPS?
ILMN trades at a trailing P/E of 34.45 on trailing EPS of 5.57516339869281 USD.
What do analysts rate ILMN?
Analyst consensus is "Buy" across 50 ratings (1 strong buy, 25 buy, 18 hold, 6 sell, 0 strong sell). Average 12-month price target: 172.44 USD.